SCHEMBL21637553

SCHEMBL21637553

CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)NCC[C@@H](O)C[C@@H](O)CC(=O)OC(C)(C)C

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 4/20 0.76
HMGCR P04035 6/20 0.74
HDAC1 Q13547 2/20 0.74
HDAC2 Q92769 2/20 0.74
HDAC6 Q9UBN7 2/20 0.74
SLCO1B1 Q9Y6L6 4/20 0.72
ABCB11 O95342 3/20 0.72
NR1I2 O75469 1/20 0.72
RHOC P08134 1/20 0.72
CYP3A4 P08684 1/20 0.72
THRB P10828 1/20 0.72
NR1H4 Q96RI1 1/20 0.72
ABCG2 Q9UNQ0 1/20 0.72
ABCC3 O15438 2/20 0.70
ABCC4 O15439 2/20 0.70
SLCO1B3 Q9NPD5 2/20 0.70
ABCB1 P08183 1/20 0.50
ABCC2 Q92887 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15475115 0.94 HMGCR (0.81) PDE6DHMGCRHDAC1HDAC2HDAC6
SCHEMBL538508 0.94 HMGCR (0.81) PDE6DHMGCRHDAC1HDAC2HDAC6
SCHEMBL538509 0.94 HMGCR (0.81) PDE6DHMGCRHDAC1HDAC2HDAC6
SCHEMBL12520033 0.94 HMGCR (0.81) PDE6DHMGCRHDAC1HDAC2HDAC6
SCHEMBL16917203 0.94 PDE6D (0.75) PDE6DHMGCRHDAC1HDAC2HDAC6
SCHEMBL18736920 0.91 HMGCR (0.88) PDE6DHMGCRHDAC1HDAC2HDAC6
SCHEMBL13734532 0.91 HMGCR (0.88) PDE6DHMGCRHDAC1HDAC2HDAC6
SCHEMBL18736918 0.91 HMGCR (0.88) PDE6DHMGCRHDAC1HDAC2HDAC6
SCHEMBL518254 0.90 HMGCR (0.73) PDE6DHMGCRHDAC1HDAC2HDAC6
SCHEMBL16917202 0.89 PDE6D (0.72) PDE6DHMGCRHDAC1HDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020016903-A1 AN IMPROVED AND COMMERCIALLY VIABLE PROCESS FOR PREPARATION OF PYRROLE DERIVATIVES WITH IMPROVED IMPURITY PROFILE & MINIMISATION OF UNIT OPERATIONS. ARCH PHARMALABS LIMITED (IN) 2020-01-23 WO disclosed